Also trades as: RENE.L (LSE) · $vol 0M
RNUGF OTC
ReNeuron Group plc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.5%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$530K
+31.5% ▲
5Y CAGR: +65.3%
Gross Profit
-$4M
+48.7% ▲
Operating Income
-$7M
+36.6% ▲
Net Income
-$5M
+44.2% ▲
EPS (Diluted)
$-0.09
+44.3% ▲
EBITDA
-$6M
+40.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $49K | $6M | $257K | $403K | $530K |
| YoY Growth | +14.0% | +12277.6% | -95.8% | +56.8% | +31.5% |
| Cost of Revenue | $16M | $16M | $10M | $8M | $4M |
| Gross Profit | -$16M | -$10M | -$9M | -$8M | -$4M |
| Gross Margin | -33055.1% | -169.3% | -3597.7% | -1902.0% | -742.1% |
| R&D Expenses | $16M | $16M | $10M | $8M | $4M |
| SG&A Expenses | $5M | $2M | $4M | $1M | $1M |
| Operating Expenses | $19M | $21M | $4M | $4M | $3M |
| Operating Income | -$18M | -$14M | -$13M | -$11M | -$7M |
| Operating Margin | -37310.2% | -237.6% | -5024.9% | -2786.1% | -1342.5% |
| Interest Expense | $39K | $42K | $32K | $25K | $20K |
| Income Before Tax | -$17M | -$14M | -$13M | -$11M | -$7M |
| Tax Expense | -$3M | -$2M | -$2M | -$1M | -$1M |
| Net Income | -$14M | -$11M | -$11M | -$10M | -$5M |
| Net Margin | -29167.3% | -188.2% | -4415.2% | -2404.2% | -1020.4% |
| EPS (Diluted) | $-0.44 | $-0.35 | $-0.29 | $-0.17 | $-0.09 |
| EBITDA | -$18M | -$13M | -$13M | -$11M | -$6M |
| Shares Outstanding | 33M | 33M | 39M | 57M | 57M |